InsiderTrades.com logo
War on Elon Escalates…
From Porter & Company   |   Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.

ILA Insider Trading

Insider Ownership Percentage: 70.09%
Insider Buying (Last 12 Months): A$1,235.28
Insider Selling (Last 12 Months): A$0.00

Island Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Island Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Island Pharmaceuticals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 11/22/2021 11:10 AM ET

This chart shows the closing price history over time for ILA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Protect Your Bank Account with THESE 4 Simple Steps
From Weiss Ratings   |   Ad
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Learn these 4 simple steps and protect your savings before it’s too late.

Island Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/19/2024David FosterInsiderBuy20,588A$0.06A$1,235.28
8/3/2022David FosterInsiderBuy31,303A$0.20A$6,323.21
6/21/2022David FosterInsiderBuy40,000A$0.13A$5,200.00
See Full Table
Urgent: This election is rigged
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Island Pharmaceuticals (ASX:ILA)

Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; and research collaboration agreement with Compounds Australia, a drug library containing various molecules that could be searched for drug re-purposing and pipeline development. It also has a cooperative research and development agreement with the U.S. Army in preparation for its Phase II clinical study for ISLA-101; supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants; and right to reference National Cancer Institute IND for Isla101. The company was incorporated in 2020 and is based in Camberwell, Australia.
Read More on Island Pharmaceuticals

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Island Pharmaceuticals?

Island Pharmaceuticals' top insider investors include:
  1. David Foster (Insider)
Learn More about top insider investors at Island Pharmaceuticals.
War on Elon Escalates…
From Porter & Company   |   Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.